Adiponectinemia Is Associated with Uricemia but Not with Proinflammatory Status in Women with Metabolic Syndrome

Table 2

Cytokines, inflammatory markers and adiponectin levels in patients with metabolic syndrome and controls.

	Metabolic Syndrome (𝑛=60)	Controls (𝑛=31)	𝑃
Leukocytes (μL^−1)	7700 (3500–13800)	6000 (3100–8600)	0.0004
Fibrinogen (mg/dL)	314.0 (185.0–489.0)	262.0 (188.0–314.0)	0.0007
CRP (mg/L)	7.80 (1.10–46.5)	0.70 (0.16–5.20)	<0.0001
Albumin (g/dL)	4.41 (3.56–5.55)	4.74 (3.75–5.47)	0.0146
C3 (mg/dL)	202.8 (115.0–271.0)	126.0 (94.8–188.0)	<0.0001
C4 (mg/dL)	43.20 (24.00–96.60)	23.50 (14.60–43.10)	<0.0001
TNF-α (pg/mL)	32.69 (11.62–193.81)	38.71 (8.58–86.26)	0.9952
IL-6 (pg/mL)	3.96 (3.04–92.45)	3.32 (2.55–9.63)	0.0373
Adiponectin (μg/mL)	7.11 (3.19–18.22)	12.31 (9.11–27.27)	0.0001

Data are median (minimum-maximum).
CRP: C-reactive protein; C3: complement factor C3; C4: complement factor C4; TNF-α: tumor necrosis factor-α; IL-6: interleukin-6.
* 𝑃≤0.05,^¤𝑃≤0.01, ^‡𝑃≤0.0001.